A Comparison of the Face Mask and Oral Mask Ventilation After Nasal Surgery

April 1, 2014 updated by: DILEK YAZICIOGLU, Diskapi Teaching and Research Hospital

A Comparison of the Face Mask and Oral Mask Ventilation After Nasal Surgery.

Difficult mask ventilation is usually studied in relation to airway management and difficult intubation and mostly during the induction period of anesthesia.

According to the closed claim reports tracheal extubation and recovery of anesthesia is associated with brain damage or death.

Difficult mask ventilation can also be a problem during the emergence phase of anesthesia after extubation. Especially after nasal surgery the use of nasal tampon and casts can resemble upper airway obstruction and facial deformity and cause difficult mask ventilation.

The effectiveness of ventilation is affected by the design of the mask. Leaks may develop due to the inability to obtain a tight seal.

The use of an oral mask for ventilation in patients with nasal tumors and after rhinoplasty for patients with a nasal cast has been reported. This suggests that oral mask ventilation, rather than face mask ventilation, should be considered after nasal surgery.

The aim of this prospective randomized study is to compare the face mask and oral mask ventilation after nasal surgery in terms of the mask ventilation classification, airway pressure, minute ventilation and tidal volume.

Our hypothesis is that ventilation with oral mask would provide better airway pressures, superior mask-ventilation classification and higher tidal volumes compared to face mask ventilation in patients with obstructed nasal pasage (nasal packing and/or cast) after nasal surgery'.

Study Overview

Status

Completed

Detailed Description

American Society of Anesthesiologists (ASA) physical class I or II, adult patients aging 19-45 yr, scheduled for nasal surgery will be recruited.

Patient characteristics will be recorded; age, gender ASA physical status, height, weight. Simple randomization will be accomplished with a computer-generated sequence of numbers and sealed envelopes will be used to allocate patients into 2 treatment sequences, Sequence O: oral mask ventilation followed by face mask ventilation and Sequence FM: face mask ventilation followed by oral mask ventilation.

Patients will be premedicated with midazolam. Ringer's lactate infusion at 15 mL•kg-1•h-1 will be initiated. Standard monitors will be established including neuromuscular monitorization and the Bispectral index monitor (BIS).

The patients head will be placed in the neutral position on a positioning pad Anesthesia will be induced with propofol 2 ml kg and fentanyl 50 mcg. Anesthesia will be maintained with oxygen in nitrous oxide and sevoflurane. The patient was ventilated trough an face mask. The appropriate size mask with the best fit will be selected and the mask size will be noted. Gas flow will be 4 L min. During the induction period the mask ventilation grade of the patients will be determined (Grade 0: ventilation by mask not attempted, Grade 1: ventilated by mask, Grade 2: ventilated by mask with oral airway or other adjuvant, Grade 3: difficult mask ventilation (inadequate, unstable, or requiring two practitioners), Grade 4: unable to mask ventilate (Han's grading scale)) and patients with Grade ≥ 2 will be excluded from the study. Muscle relaxation and intubation will be facilitated with rocuronium 0.6 mg kg-1. At the end of surgery trachea will be extubated when TOF 0.9 is obtained and the patient is spontaneous breathing, meanwhile inhalation anesthesia will be continued (BIS 50-70). After extubation, spontaneous ventilation will be assisted with mask ventilation. Mask ventilation will be applied according to sequence allocation and the mask ventilation grades with each mask technique will be determined with the same grading system. Spontaneous ventilation will be assisted with mask ventilation.

The face mask will be applied with the one handed EC-clamp technique. The mask will be placed over the bridge of the nose and mouth and a chin-lift, head tilt maneuver will be used. The oral mask; size 1 or 2 child's mask will be placed only over the mouth and the one handed EC-clamp technique with the chin-lift, head tilt maneuver will be used again. The masks will be changed after three consecutive measurements for each mask technique and the crossover time will be short.

The respiratory parameters will be measured with the monitor contained in the Drager Primus anesthesia machine. The observer providing mask ventilation is experienced in mask ventilation and will be blinded to the monitor display. All patients will be ventilated by the same observer. Data will be recorded by independent residents. The mask ventilation classification will be recorded. mean airway pressure (Pmean), maximum airway pressure (Ppeak) , tidal volume (TV), expired tidal volume (TVe) minute volume leak (MVleak) and minute volume (MV) will be recorded during spontaneous ventilation. Volatile anesthesia will be ceased after observing that the patients are calm and not coughing and the respiratory measures will be evaluated thereafter. The APL (airway pressure release) valve will be closed during the evaluation of mask ventilation. Sufficient chest movement, mask leak, gastric insufflations will be assessed. Indicators for difficult mask ventilation are defined as; TV< 4 ml kg, inadequate chest movements, the need for an oropharyngeal airway, two handed mask ventilation, need to increase the gas flow, gastric insufflations, need to ventilate with two operators.

It was planned to enroll 30 patients in this study. After performing a pilot study we calculated that 10 patients in each group was sufficient to detect a difference between groups concerning tidal volume with 0.95 power and 0.05 alfa error. We decided to enroll 24 patients in the study due to possible drop outs.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey
        • Ankara Diskapi Yildirim Beyazit Teaching and Research Hospital
      • Ankara, Turkey
        • Diskapi Yildirim Beyazit Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 45 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • American Society of Anesthesiologists (ASA) physical class I or II
  • adult patients
  • ageing 19-45 yr
  • scheduled for nasal surgery

Exclusion Criteria:

  • Respiratory diseases
  • snoring
  • smoking
  • obstructive sleep apnea
  • obesity (body mass index >30 kg m2)
  • difficult intubation-ventilation-airway
  • emergency cases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Face Mask
Patients will be ventilated with a face mask first and with a oral mask thereafter
Patients will be ventilated trough a face mask first and trough a oral mask thereafter
Other Names:
  • Adult anesthesia face mask
  • Rusch reusable anatomical black rubber adult face mask
EXPERIMENTAL: Oral Mask
Patients will be ventilated trough an oral mask first and trough a face mask thereafter
Patients will be ventilated trough an oral mask first and trough a face mask thereafter
Other Names:
  • Pediatric anesthesia face mask
  • Rusch reusable anatomical black rubber pediatric mask

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tidal volume
Time Frame: 5 min after extubation
assessment will be done after extubation, when the spontaneous respiratory rate is 10 breaths/min.
5 min after extubation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mask ventilation grade of the patients as Grade0, grade 1, Grade 2, grade 3, grade 4
Time Frame: 5 min after extubation
Assessment will be done after extubation
5 min after extubation

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ppeak
Time Frame: 5 m extubationin after
assessment will be done after extubation, when the spontaneous respiratory rate is 10 breaths/min.
5 m extubationin after
Pmean
Time Frame: 5 min after extubation
assessment will be done after extubation, when the spontaneous respiratory rate is 10 breaths/min.
5 min after extubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Murat Sayın, Ass Prof, Ankara Diskapi Yildirim Beyazit Teaching and Research Hospital, Turkey.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (ACTUAL)

December 1, 2013

Study Completion (ACTUAL)

December 1, 2013

Study Registration Dates

First Submitted

May 15, 2013

First Submitted That Met QC Criteria

June 4, 2013

First Posted (ESTIMATE)

June 5, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

April 2, 2014

Last Update Submitted That Met QC Criteria

April 1, 2014

Last Verified

May 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nasal Septum Deviation

Clinical Trials on Face Mask

Subscribe